Top Markets
Coin of the day
GRAIL Inc. GRAIL Inc.

GRAIL Inc.

GRAL
Classifica tra le azioni #4689
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early... GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted methylation-based platform that enables applications for disease prognostication, risk stratification, minimal residual disease detection, and recurrence and relapse monitoring. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Prezzo delle azioni
$79.40
Ultima sincronizzazione: 2026-08-26
Capitalizzazione di mercato
$3.41B
Variazione (1 giorno)
-3.80%
Variazione (1 anno)
136.10%
Paese
US
Scambia GRAIL Inc. (GRAL)

Categoria

Storico del rendimento da dividendi per GRAIL Inc. (GRAL)
Il rendimento da dividendi (TTM) di GRAIL Inc. (simbolo azionario: GRAL) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per GRAIL Inc. (GRAL) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH